Haemonetics Corp [HAE] stock prices are up 1.87% to $74.77 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HAE shares have gain 6.72% over the last week, with a monthly amount glided 9.97%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Haemonetics Corp [NYSE: HAE] stock has seen the most recent analyst activity on June 26, 2025, when Robert W. Baird initiated its Outperform rating and assigned the stock a price target of $87. Previously, BofA Securities downgraded its rating to Underperform on February 07, 2025, and dropped its price target to $68. On December 06, 2024, JP Morgan initiated with a Overweight rating and assigned a price target of $116 on the stock. Raymond James upgraded its rating to a Strong Buy but stick to its price target of $120 on November 08, 2024. CL King initiated its recommendation with a Buy and recommended $116 as its price target on September 13, 2024. BofA Securities started tracking with a Neutral rating for this stock on September 11, 2024, and assigned it a price target of $85. In a note dated September 10, 2024, BTIG Research initiated an Buy rating and provided a target price of $112 on this stock.
The stock price of Haemonetics Corp [HAE] has been fluctuating between $55.30 and $94.99 over the past year. Currently, Wall Street analysts expect the stock to reach $108.25 within the next 12 months. Haemonetics Corp [NYSE: HAE] shares were valued at $74.77 at the most recent close of the market. An investor can expect a potential return of 44.78% based on the average HAE price forecast.
Analyzing the HAE fundamentals
The Haemonetics Corp [NYSE:HAE] reported sales of 1.36B for trailing twelve months, representing a drop of -3.70%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.18 and Total Capital is 0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.29.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 73.62 points at the first support level, and at 72.48 for the second support level. However, for the 1st resistance point, the stock is sitting at 75.75, and for the 2nd resistance point, it is at 76.74.
Ratios To Look Out For
It’s worth pointing out that Haemonetics Corp [NYSE:HAE]’s Current Ratio is 1.62. In addition, the Quick Ratio stands at 0.99 and the Cash Ratio stands at 0.53. Considering the valuation of this stock, the price to sales ratio is 2.64, the price to book ratio is 4.39 and price to earnings (TTM) ratio is 22.54.
Transactions by insiders
Recent insider trading involved Llorens Josep, Former Officer, that happened on Jun 26 ’25 when 18630.0 shares were purchased. Former Officer, Strong Stewart W completed a deal on Jun 12 ’25 to buy 708.0 shares. Meanwhile, Officer Strong Stewart W bought 7705.0 shares on Jun 04 ’25.
